Jablonska, K.; Nowinska, K.; Piotrowska, A.; Partynska, A.; Katnik, E.; Pawelczyk, K.; Kmiecik, A.; Glatzel-Plucinska, N.; Podhorska-Okolow, M.; Dziegiel, P.
Prognostic Impact of Melatonin Receptors MT1 and MT2 in Non-Small Cell Lung Cancer (NSCLC). Cancers 2019, 11, 1001.
https://doi.org/10.3390/cancers11071001
AMA Style
Jablonska K, Nowinska K, Piotrowska A, Partynska A, Katnik E, Pawelczyk K, Kmiecik A, Glatzel-Plucinska N, Podhorska-Okolow M, Dziegiel P.
Prognostic Impact of Melatonin Receptors MT1 and MT2 in Non-Small Cell Lung Cancer (NSCLC). Cancers. 2019; 11(7):1001.
https://doi.org/10.3390/cancers11071001
Chicago/Turabian Style
Jablonska, Karolina, Katarzyna Nowinska, Aleksandra Piotrowska, Aleksandra Partynska, Ewa Katnik, Konrad Pawelczyk, Alicja Kmiecik, Natalia Glatzel-Plucinska, Marzenna Podhorska-Okolow, and Piotr Dziegiel.
2019. "Prognostic Impact of Melatonin Receptors MT1 and MT2 in Non-Small Cell Lung Cancer (NSCLC)" Cancers 11, no. 7: 1001.
https://doi.org/10.3390/cancers11071001
APA Style
Jablonska, K., Nowinska, K., Piotrowska, A., Partynska, A., Katnik, E., Pawelczyk, K., Kmiecik, A., Glatzel-Plucinska, N., Podhorska-Okolow, M., & Dziegiel, P.
(2019). Prognostic Impact of Melatonin Receptors MT1 and MT2 in Non-Small Cell Lung Cancer (NSCLC). Cancers, 11(7), 1001.
https://doi.org/10.3390/cancers11071001